BFC Planning’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
BFC Planning's TEVA Position: Q3 2026 in Review
BFC Planning reduced its Teva Pharmaceutical Industries (TEVA) stake by 4% in Q3 2026, selling an estimated $7.15K and leaving 4,789 shares worth $190K. The position accounts for 0.01% of the portfolio, ranked #951.
BFC Planning first reported a position in TEVA in Q3 2024 and has held it in 8 quarters since. The position peaked at $258K in Q4 2025. 486 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- BFC Planning held 4,789 shares of Teva Pharmaceutical Industries worth $190K as of Q3 2026.
- BFC Planning sold 200 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $7.15K.
- Teva Pharmaceutical Industries made up 0.01% of BFC Planning's portfolio in Q3 2026, its #951 holding.
- BFC Planning first reported a position in Teva Pharmaceutical Industries in Q3 2024 and has held it in 8 quarters since.
- BFC Planning's Teva Pharmaceutical Industries position peaked at $258K in Q4 2025.
- 486 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.